0001209191-18-002238.txt : 20180104 0001209191-18-002238.hdr.sgml : 20180104 20180104190058 ACCESSION NUMBER: 0001209191-18-002238 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180102 FILED AS OF DATE: 20180104 DATE AS OF CHANGE: 20180104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Goldberg Jeff Marc CENTRAL INDEX KEY: 0001703061 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38137 FILM NUMBER: 18511640 MAIL ADDRESS: STREET 1: C/O AKCEA THERAPEUTICS STREET 2: 55 CAMBRIDGE PARKWAY, STE 100 CITY: CAMBRIDGE STATE: MA ZIP: 02142 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AKCEA THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001662524 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472608175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 55 CAMBRIDGE PARKWAY STREET 2: SUITE 100 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 760-603-2732 MAIL ADDRESS: STREET 1: 2855 GAZELLE CT CITY: CARLSBAD STATE: CA ZIP: 92010 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-01-02 0 0001662524 AKCEA THERAPEUTICS, INC. AKCA 0001703061 Goldberg Jeff Marc C/O AKCEA THERAPEUTICS, INC. 55 CAMBRIDGE PARKWAY CAMBRIDGE MA 02142 0 1 0 0 Chief Operating Officer Common Stock 2018-01-01 4 J 0 989 6.80 A 989 D Stock Option (right to buy) 17.38 2018-01-02 4 A 0 110000 0.00 A 2028-01-01 Common Stock 110000 110000 D Although not required, the Reporting Person is voluntarily reporting the acquisition of 989 shares on January 1, 2018 pursuant to the Issuer's Employee Stock Purchase Plan. The shares vest as follows: 1/4th of the shares vest one year after January 2, 2018; 1/48th of the shares vest monthly thereafter over the next three years. /s/ Paula Soteropoulos, Attorney-in-Fact 2018-01-04